I am personally invested in Keytruda, had metastatic melanoma with a tiny chance of survival but after starting Keytruda both tumours disappeared in a few months and have never come back after more than 7 years. So the FDA made the right decision in my opinion.
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L, page-199
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.39 |
Change
-0.075(5.12%) |
Mkt cap ! $1.587B | |||
| Open | High | Low | Value | Volume |
| $1.45 | $1.46 | $1.37 | $9.337M | 6.672M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 80200 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 28642 | 2 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |